Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs

DR Tompa, A Immanuel, S Srikanth… - International journal of …, 2021 - Elsevier
The infectious microscopic viruses invade living cells to reproduce themselves, and causes
chronic infections such as HIV/AIDS, hepatitis B and C, flu, etc. in humans which may lead to …

Approved antiviral drugs over the past 50 years

E De Clercq, G Li - Clinical microbiology reviews, 2016 - Am Soc Microbiol
Since the first antiviral drug, idoxuridine, was approved in 1963, 90 antiviral drugs
categorized into 13 functional groups have been formally approved for the treatment of the …

[HTML][HTML] Genital warts: a comprehensive review

VR Yanofsky, RV Patel… - The Journal of clinical and …, 2012 - ncbi.nlm.nih.gov
External genital warts, also known as condylomata acuminata, are extremely common, with
between 500,000 to one million new cases diagnosed each year in the United States alone …

External genital warts: diagnosis, treatment, and prevention

DJ Wiley, J Douglas, K Beutner, T Cox… - Clinical Infectious …, 2002 - academic.oup.com
External genital warts (EGWs) are visible warts that occur in the perigenital and perianal
regions. They are due primarily to non-oncogenic human papillomavirus (HPV) types …

Current and future direction in treatment of HPV-related cervical disease

N Khairkhah, A Bolhassani, R Najafipour - Journal of Molecular Medicine, 2022 - Springer
Human papillomavirus (HPV) is the most common sexually transmitted virus in the world.
About 70% of cervical cancers are caused by the most oncogenic HPV genotypes of 16 and …

Treatment of genital warts with an immune-response modifier (imiquimod)

KR Beutner, SL Spruance, AJ Hougham, TL Fox… - Journal of the American …, 1998 - Elsevier
Background: Genital warts are a common sexually transmitted disease caused by human
papillomavirus. Imiquimod is a novel immune-response modifier capable of inducing a …

Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts

KR Beutner, SK Tyring, KF Trofatter Jr… - Antimicrobial agents …, 1998 - Am Soc Microbiol
Genital human papillomavirus infection is one of the most common sexually transmitted
diseases. Imiquimod is a new agent, an immune-response modifier, that has been …

Position statement for the diagnosis and management of anogenital warts

C O'Mahony, M Gomberg, M Skerlev… - Journal of the …, 2019 - Wiley Online Library
Background Anogenital warts (AGW) can cause economic burden on healthcare systems
and are associated with emotional, psychological and physical issues. Objective To provide …

Therapeutic approaches to genital warts

KR Beutner, A Ferenczy - The American journal of medicine, 1997 - Elsevier
Although many treatments are available for genital warts caused by human papillomavirus
(HPV), none are uniformly successful in the treatment of this disease. Most current treatment …

Human papillomavirus–related genital disease in the immunocompromised host: Part II

RH Gormley, CL Kovarik - Journal of the American Academy of …, 2012 - Elsevier
Human papillomavirus is responsible for common condyloma acuminata and a number of
premalignant and malignant anogenital lesions. The immunocompromised population is at …